Acute respiratory distress syndrome pathophysiology
|
Acute respiratory distress syndrome Microchapters |
|
Differentiating Acute respiratory distress syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute respiratory distress syndrome pathophysiology On the Web |
|
American Roentgen Ray Society Images of Acute respiratory distress syndrome pathophysiology |
|
Acute respiratory distress syndrome pathophysiology in the news |
|
Blogs on Acute respiratory distress syndrome pathophysiology |
|
Directions to Hospitals Treating Acute respiratory distress syndrome |
|
Risk calculators and risk factors for Acute respiratory distress syndrome pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Acute respiratory distress syndrome primarily results from the diffuse inflammation of lung parenchyma. Loss of aeration can cause fundamental changes in inflammation amplification and progression.
Pathophysiology
- ARDS is characterized by a diffuse inflammation of lung parenchyma.
- The triggering insult to the parenchyma usually results in an initial release of cytokines and other inflammatory mediators, secreted by local epithelial and endothelial cells.
- Neutrophils and some T-lymphocytes quickly migrate into the inflamed lung parynchema and contribute in the amplification of the phenomenon.
- Typical histological presentation involves diffuse alveolar damage and hyaline membrane formation in alveolar walls.
- Although the triggering mechanisms are not completely understood, recent research has examined the role of inflammation and mechanical stress.
Inflammation
- Inflammation alone, as in sepsis, causes:
- Endothelial dysfunction
- Fluid extravasation from the capillaries
- Impaired drainage of fluid from the lungs
- Dysfunction of type II pulmonary epithelial cells may also be present, with a concomitant reduction in surfactant production.
- Elevated inspired oxygen concentration often becomes necessary at this stage, and they may facilitate a 'respiratory burst' in immune cells.
- In a secondary phase, endothelial dysfunction causes cells and inflammatory exudate to enter the alveoli
- This pulmonary edema increases the thickness of the alveolo-capillary space, increasing the distance the oxygen must diffuse to reach blood.
- This impairs gas exchange leading to hypoxia, increases the work of breathing, eventually induces fibrosis of the airspace.
- Rdema and decreased surfactant production by type II pneumocytes may cause whole alveoli to collapse, or to completely flood. This loss of aeration contributes further to the right-to-left shunt in ARDS.
- As the alveoli contain progressively less gas, more blood flows through them without being oxygenated resulting in massive intrapulmonary shunting.
- Collapsed alveoli (and small bronchi) do not allow gas exchange. It is not uncommon to see patients with a PaO2 of 60 mmHg (8.0 kPa) despite mechanical ventilation with 100% inspired oxygen.
- The loss of aeration may follow different patterns according to the nature of the underlying disease, and other factors. In pneumonia-induced ARDS, for example, large, more commonly causes relatively compact areas of alveolar infiltrates.
- Usually distributed to the lower lobes, in their posterior segments, and they roughly correspond to the initial infected area.
- In sepsis or trauma-induced ARDS, infiltrates are usually more patchy and diffuse. The posterior and basal segments are always more affected, but the distribution is even less homogeneous.
- Loss of aeration also causes important changes in lung mechanical properties. These alterations are fundamental in the process of inflammation amplification and progression to ARDS in mechanically ventilated patients.